Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 22, 2008

Primary Completion Date

April 20, 2012

Study Completion Date

April 20, 2012

Conditions
Lymphoma, Mantle- Cell
Interventions
DRUG

Everolimus

Everolimus tablets

Trial Locations (31)

10016

New York University Medical Center NYU Cancer Institute, New York

15224

Western Pennsylvania Cancer Institute /Western Penn Hospital Western Pann. Cancer Inst., Pittsburgh

15232

University of Pittsburgh Medical Center Hillman Cancer Center (4), Pittsburgh

26506

West Virginia University/ Mary Babb Randolph Cancer Center, Morgantown

27858

East Carolina University BrodySchool of Medicine, Greenville

29605

Cancer Centers of the Carolinas CC of C -Eastside, Greenville

30912

Georgia Health Sciences University Dept. of MCG, Augusta

33176

Advanced Medical Specialties Medical Onc Hem, Miami

37212

Vanderbilt University Medical Center, Clinical Trials Center Dept. of VUMC, Nashville

46107

St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2), Beech Grove

46227

Central Indiana Cancer Centers CICC - East (2), Indianapolis

55905

Mayo Clinic - Rochester Hematology, Rochester

60611

Northwestern University, Chicago

63110

Washington University School Of Medicine-Siteman Cancer Ctr Medical Oncology, St Louis

72703

Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville

75246

Baylor College of Medicine Dept. of Sammons Cancer (2), Dallas

75702

Tyler Cancer Center Dept.ofTylerCancerCtr., Tyler

80121

Rocky Mountain Cancer Centers RMCC - Denver-Midtown, Greenwood Village

85259

Mayo Clinic - Arizona Mayo Clinic - Scottsdale, Multiple Locations

90095

UCLA/ University of California Los Angeles Dept.of Hem/Oncology, Los Angeles

94520

Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord

95817

University of California Davis Cancer Center Dept. of UC Davis Cancer (4), Sacramento

97210

Northwest Cancer Specialists Vancouver Cancer Center (2), Portland

97227

Kaiser Permanente Northwest Dept of Kaiser Northwest (3), Portland

99202

Cancer Care Northwest CC Northwest- Spokane South(3), Spokane

91010-3000

City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte

48109-0944

University of Michigan Comprehensive Cancer Center Dept of Michigan Cancer Center, Ann Arbor

07601

Hackensack University Medical Center Dept ofHackensackUniversityMC, Hackensack

19111-2497

Fox Chase Cancer Center Regulatory Contact, Philadelphia

75390-8527

University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(2), Dallas

77030-4009

MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (10), Houston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY